1 |
Korea Central Cancer Registry, National Cancer Center, "Annual report of cancer statistics in Korea in 2012", Ministry of Health and Welfare, 2014.
|
2 |
Korean Consumer Agency, Press Release, December, 2013, internet by http://www.kca.go.kr/
|
3 |
www.cancer.go.kr/
|
4 |
H. I. Seo, D. Y. Park, S. J. Kim, "Clinical Impact of 18-FDG PET-CT in Ampulla of Vater Cancer," J. Korean Surg. Soc., Vol. 81, No. 5, pp.234-234, 2011.
|
5 |
W. I. Chang, B. J. Kim, J. K. Lee, P. Kang, K. H. Lee, K. T. Lee, J. C. Rhee, K. T. Jang, S. H. Choi, D. W. Choi, D. I. Choi, J. H. Lim, "The clinical and radiological characteristics of focal mass-forming au toimmune pancreatitis: comparison with chronic pancr eatitis and pancreatic cancer, Pancreas, Vol. 38, No. 4, pp. 401-408, 2009.
DOI
|
6 |
T. Kamisawa, M. Imai, P. Yui Chen, Y. Tu, N. Egawa, K. Tsuruta, A. Okamoto, M. Suzuki, N. Kamata, "Strategy for differentiating autoimmune pancreatitis from pancreatic cancer," Pancreas, Vol 37, No. 3, pp. e62-e67, 2008.
DOI
|
7 |
S. S. Park, K. T. Lee, K. H. Lee, J. K. Lee, S. H. Kim, J. Y. Choi, J. C. Rhee, "Diagnostic usefulness of PET/CT for pancreatic malignancy," Korean J. Gastroenterol., Vol. 54, No. 4, pp. 235-242, 2009.
DOI
|
8 |
J. K. Lee, "Distinguishing AIP from Pancreatic Cancer Based on Pancreas Imaging," J. Korean Pancreas & Biliary Track Asso., Vol 15, No 3, pp. 341-344, 2010.
|
9 |
J. S. Kim, S. T. Lim, Y. J. Jeong, D. W. Kim, H. J. Jeong, M. H. Sohn, "The Clinical Value of Dual Time Point F-18 FDG PET/CT Imaging for the Differentiation of Colonic Focal Uptake Lesions," Nucl. Med. Mol. Imaging, Vol 43, No 4, pp 309-316, 2009.
|
10 |
H. Zhuang, M. Pourdehnad, E. S. Lambright, A. J. Y amamoto, M. M. Lanuti, P. Li, P. D. Mozley, M. D. Rossman, S. M. Albelda, A. Alavi, "Dual time point 18F-FDG PET imaging for differentiating malignant from inflammatory processes," J. Nucl. Med., Vol. 42, No. 9, pp. 1412-1417, 2001.
|
11 |
M. A. Lodge, J. D. Lucas, P. K. Marsden, B. F. Cronin, M. J. O'Doherty, M. A. Smith, "A PET study of 18F-FDG uptake in soft tissue masses," Eur. J. Nucl. Med. Mol. Imaging, Vol. 26, No. 1, pp. 22-30, 1999.
DOI
|
12 |
S. Yamada, K. Kubota, R. Kubota, T. Ido, N. Tamahashi, "High accumulation of fluorine-18-fluorodeoxy glucose in turpentine induced inflammatory tissue," J. Nuc. Med., Vol. 36, No. 11 pp 1301-1306, 1995.
|
13 |
W. H. Choi, I. R. Yoo, J. H. O, S. H. Kim, S. K. Chung, "The value of dual-time-point 18F-FDG PET/CT for identifying axillary lymph node meta stasis in breast cancer patients," Br. J. Radiol., Vol. 84, No. 1003, pp. 593-599, 2011.
DOI
|
14 |
H. Y. Lee, "The analysis of F18-FDG PET/ CT Images According to the Time Flow," J. Korean Soc. of Radiol., Vol. 6, No. 1, pp. 47-51, 2012.
DOI
|
15 |
L. M. Hamberg, G. J. Hunter, N. M. Alpert, N. C. Choi, J. W. Babich, A. J. Fischman, "The dose uptake ratio as an index of glucos metabolism useful para meter or oversimplification," J. Nuc. Med., Vol. 35, No. 11, pp. 1308-1312, 1994.
|
16 |
J. A. Swets, "Measuring the accuracy of diagnostic systems," Science, Vol. 240, No. 4857, pp. 1285-1293, 1988.
DOI
|
17 |
M. Greiner, D. Pfeiffer, R. D. Smith, "Principles and practical application of the receiver-operating characteristic analysis for diagnostic tests," Prev. Vet. Med., Vol 45, Np. 1-2, pp. 25-41, 2000.
|
18 |
J. C. Mansour, L. Schwartz, N. Pandit-Taskar, M. D' Angelica, Y. Fong, S. M. Larson, M. F. Brennan, P. J. Allen, "The utility of F-18 fluorodeoxyglucose whole body PET imaging for determining malignancy in cystic lesions of the pancreas," J. Gastrointest Surg., Vol. 10, No. 10, pp. 1354-1360, 2006.
DOI
|